« Back
Home /
Atraric acid

Atraric acid

Item no.	TMO-TCS1372-5mg
Manufacturer	TargetMol
Amount	5mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	99.27%
Citations	PTP1B inhibitory secondary metabolites from the Antarctic lichen Lecidella carpathica. Mycology An International Journal on Fungal Biology, 2011, 2(1):18-23.
Smiles	CC1=CC(=C(C(=C1C(=O)OC)O)C)O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	4707-47-5, Androgen Receptor; Phosphatase
Available
Bioactivity	Atraric acid derivatives as a new chemical lead structure for novel therapeutic compounds as AR antagonists, that can be used for prophylaxis or treatment of prostatic diseases. It inhibits PTP1B activity in a dose-dependent manner with IC50 values of 51.5 uM, suggest that atraric acid has potential to treat diabetes.
MolWt	196.2
Pathway	Endocrinology/Hormones; Metabolism
Receptor	Androgen Receptor; PTP1B

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5mg

available

Delivery expected until 8/23/2024

Express Delivery: Save 4 days

Compare

Add to wishlist

Recommend by mail